HE4 in gynecological cancers: report of a European investigators and experts meeting
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F12%3A%230000457" target="_blank" >RIV/00209805:_____/12:#0000457 - isvavai.cz</a>
Result on the web
<a href="http://www.ncbi.nlm.nih.gov/pubmed?term=HE4%20Study%20Group%5BCorporate%20Author%5D" target="_blank" >http://www.ncbi.nlm.nih.gov/pubmed?term=HE4%20Study%20Group%5BCorporate%20Author%5D</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1515/cclm-2012-0373" target="_blank" >10.1515/cclm-2012-0373</a>
Alternative languages
Result language
angličtina
Original language name
HE4 in gynecological cancers: report of a European investigators and experts meeting
Original language description
The HE4 protein, which belongs to the "four disulfide" acid protein group, has emerged as one of the most promising biomarkers in gynecologic oncology. An expert meeting on the analytical and clinical performance of the quantitative determination of HE4was held in November 2011, involving 25 clinical and laboratory specialists from 16 European countries. The aim of the meeting was to present and discuss the results of recent studies on the use of HE4 and on the Risk of Ovarian Malignancy Algorithm (ROMA), which combines the results of HE4 and CA 125. The meeting was structured in separate sessions focusing on ovarian cancer risk stratification, differential diagnosis, prognosis and monitoring and with diagnosis and monitoring of endometrial cancer. Wepresent here a summary of the data and evidence, presented, together with consensus statements on the different topics, where available, and suggestions for further studies and evaluations required to establish optimal use of HE4, either
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Clinical Chemistry and Laboratory Medicine
ISSN
1434-6621
e-ISSN
—
Volume of the periodical
50
Issue of the periodical within the volume
12
Country of publishing house
DE - GERMANY
Number of pages
10
Pages from-to
2127-2136
UT code for WoS article
000311899200008
EID of the result in the Scopus database
—